| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-14 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-12 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-12 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-12 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-12 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-12 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-11 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-10 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-10 |